JAMA podcast on racism in medicine faces backlashMarch 5, 2021Diversity in MedicinePatient & Survivor CareMixed Topics
New ASH guidelines: VTE prevention and treatment in cancer patientsMarch 2, 2021ThrombosisPatient & Survivor Care
COVID-19 vaccination in cancer patients: NCCN outlines prioritiesFebruary 1, 2021COVID-19 UpdatesTransplantPatient & Survivor Care
Model predicts acute kidney injury in cancer patients a month in advanceFebruary 1, 2021Patient & Survivor Care
Medicaid to cover routine costs for patients in trialsJanuary 4, 2021Patient & Survivor CareMixed Topics
COVID-19 vaccines and cancer patients: 4 things to knowDecember 21, 2020Patient & Survivor CareCOVID-19 Updates
Extended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Patient & Survivor CareCOVID-19 UpdatesTransplantMultiple MyelomaMyelodysplastic Syndrome
‘Practice changing’: Ruxolitinib as second-line in chronic GVHDDecember 8, 2020TransplantPatient & Survivor Care
No benefit from tranexamic acid prophylaxis in blood cancersDecember 7, 2020ThrombosisPatient & Survivor CareBleeding Disorders
VTE prophylaxis is feasible, effective in some high-risk cancer patientsDecember 4, 2020ThrombosisPatient & Survivor Care
What to do when anticoagulation fails cancer patientsDecember 1, 2020ThrombosisPatient & Survivor Care
Hemochromatosis variants may confer 10-fold higher risk of liver cancerNovember 30, 2020Transfusion MedicinePatient & Survivor CareBleeding Disorders
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggestNovember 25, 2020Patient & Survivor CareCOVID-19 Updates
New cancer drugs may have saved more than 1.2 million AmericansNovember 12, 2020Patient & Survivor Care
